M. Boumans

Most-cited papers

1. Relationship between the type I interferon signature and the response to rituximab in rheumatoid arthritis patients.

   R. Thurlings, M. Boumans, J. Tekstra, J. V. van Roon +10 more

   2010Arthritis & Rheumatism136 citations

   Semantic Scholar

   Save

2. Effect of rituximab treatment on T and B cell subsets in lymph node biopsies of patients with rheumatoid arthritis

   T. Ramwadhdoebé, L. V. van Baarsen, M. Boumans, S. Bruijnen +7 more

   2019Rheumatology134 citations Open access

   Semantic Scholar

   Save

3. Brief report: a phase IIa, randomized, double-blind, placebo-controlled trial of apilimod mesylate, an interleukin-12/interleukin-23 inhibitor, in patients with rheumatoid arthritis.

   S. Krausz, M. Boumans, D. Gerlag, J. Lufkin +8 more

   2012Arthritis & Rheumatism80 citations

   Semantic Scholar

   Save

4. Presence of lymphocyte aggregates in the synovium of patients with early arthritis in relationship to diagnosis and outcome: is it a constant feature over time?

   M. V. D. van de Sande, R. Thurlings, M. Boumans, C. Wijbrandts +3 more

   2010Annals of the Rheumatic Diseases58 citations

   Semantic Scholar

   Save

5. Hunting for the pathogenesis of rheumatoid arthritis: core-needle biopsy of inguinal lymph nodes as a new research tool

   M. D. de Hair, IJsbrand A. J. Zijlstra, M. Boumans, M. V. D. van de Sande +3 more

   2012Annals of the Rheumatic Diseases49 citations

   Semantic Scholar

   Save

6. Response to rituximab in patients with rheumatoid arthritis in different compartments of the immune system.

   M. Boumans, R. Thurlings, D. Gerlag, K. Vos +1 more

   2011Arthritis & Rheumatism38 citations

   Semantic Scholar

   Save

7. Targeted therapies in rheumatoid arthritis

   M. Boumans

   201220 citations

   Semantic Scholar

   Save

8. The relationship between the type I interferon signature and the response to rituximab in rheumatoid arthritis

   R. Thurlings, M. Boumans, J. Tekstra, K. Vos +8 more

   201017 citations Open access

   Semantic Scholar

   Save

9. Rituximab treatment in rheumatoid arthritis: how does it work?

   M. Boumans, P. Tak

   2009Arthritis Research & Therapy8 citations Open access

   Semantic Scholar

   Save

10. Concise Report

    M. Boumans, O. Teng, R. Thurlings, J. Bijlsma +8 more

    3 citations

    Semantic Scholar

    Save

11. Rituximab abrogates joint destruction in rheumatoid arthritis by inhibiting osteoclastogenesis

    M. Boumans, R. Thurlings, L. Yeo, D. Scheel-Toellner +3 more

    2011Annals of the Rheumatic Diseases1 citations

    Semantic Scholar

    Save

12. Splenic neuromodulation as monotherapy and in combination with biologic or targeted synthetic DMARDs for difficult-to-treat rheumatoid arthritis (ConsiderRAte): a randomised, sham-controlled, early feasibility trial

    S. Tas, J. Christiaans, M. Boumans, F. Koopman +27 more

    2026EClinicalMedicine0 citations Open access

    Semantic Scholar

    Save

13. A1.73 Relationship between expression of synovial B cell survival factors and clinical response to rituximab treatment in rheumatoid arthritis

    R. Thurlings, M. Boumans, W. de Jager, K. Vos +5 more

    20140 citations

    Semantic Scholar

    Save

14. Clinical and molecular classification of very early arthritis patients

    M. V. D. van de Sande, R. Thurlings, M. Boumans, C. Wijbrandts +3 more

    0 citations

    Semantic Scholar

    Save